Management Team2018-11-06T22:28:28+00:00

Management Team

Said Sebti, PhD
Chief Scientific Officer

  • Professor and Chair, Department of Drug Discovery – Moffitt Cancer Center
  • Co-inventor of PTX-100 & PTX-200
  • Named among top 20 Translational Researchers in the world by Nature Publishing Group

Terry Chew, M.D.
Chief Medical Officer

  • Hematologist/oncologist with 20 years experience in biotech & pharma
  • 5 New Drug Applications including DaunoXome, Taxotere and DepoCyte
  • PTX is only 1 of only 2 ASX biotechs with a CMO that has successfully approved drugs

Ajay Upadhyay
VP – Clinical Operations

  • 24 years in clinical drug development
  • Former Executive Director, Clinical and Outcomes Sciences – Medical Affairs at Astellas Pharma
  • Former Chief of Staff, US Oncology Business unit at GSK

Jim Winkler
VP – Business Development

  • VP Drug Discovery & Biology at Array BioPharma
  • Key member in Array’s partnership deals
  • Director of Oncology Research, GSK

Mike Preigh, PhD
VP – CMC

  • Led CMC at Array BioPharma for 10 years
  • Successfully brought >20 drug candidates to IND & clinical development
  • Previously Pfizer

Claudia Gregorio-King, PhD
VP – Operations

  • Extensive experience in the management of pre-clinical and clinical research and intellectual property
  • Regulatory affairs and clinical project management experience with small and large CROs

Chaline Strickland, Pharm.D.
Regulatory Affairs

  • Senior Director of Clinical Affairs at Ground Zero Pharmaceuticals
  • Involved in dozens of New Drug Applications